The skilled and experienced neurosurgery team at Mount Sinai Morningside and Mount Sinai West are recognized as having one of the nation's best Neurosurgery programs by U.S. News & World Report® for 2023-24. We are particularly skilled with epilepsy surgery, cerebrovascular services, essential tremor, Parkinson’s Disease, psychiatric disorders, and general brain and spine procedures.
We have extensive experience performing Chiari malformation procedures, cerebrospinal diversions, intracranial hemorrhage evacuation, intrathecal pumps (for pain and spasticity), spinal cord and vagal nerve stimulation, cervical and lumbar disc replacement procedures, minimally invasive spine surgeries, and microdiscectomies, spinal fusions, and radiosurgery.
Our state-of-the-art technology includes the ROSA™ robotic surgical assistive device used for accurately mapping the source of epileptic seizures, and for surgical removal of the tissue causing the seizure. We use the MONTERIS Neuroblate™ system to perform minimally invasive laser treatment of epilepsy foci, which helps us reach difficult-to-access areas of the brain through a 2 mm burr hole. In addition, we have a dedicated neurosurgical intensive care unit at the hospital. Learn more.
We are one of the busiest neuromodulation centers in the United States, treating movement and psychiatric disorders and pioneering treatments and new deep brain stimulation technologies. Patients come to us for neuromodulation services from all over the world.
Essential Tremor and Tremor Dominant Parkinson’s Disease
Our state-of-the art facility offers the latest in neurosurgical care including lifesaving medications and new procedures to treat patients with movement disorders. One of our newest technologies, MR guided Focused Ultrasound, often provides immediate relief to for essential tremor and tremor-dominant Parkinson’s disease patients. Learn more.
This incisionless procedure uses ultrasound to target and ablate, or burn, areas of the brain that are causing tremors. This outpatient procedure, which lasts about three hours, is performed in an MRI scanner. No anesthesia is necessary and patients recover quickly and are able to return to everyday activities.
Our intracerebral hemorrhage (ICH) program is on route to becoming an Intracerebral Hemorrhage Center of Excellence for all of the Mount Sinai Health System. Whenever a patient with ICH enters a Mount Sinai hospital, we evaluate and transfer the person to Mount Sinai West. When possible, we perform minimally invasive clot evacuation. Dr. J Mocco is the Principal Investigator for a clinical trial to evaluate minimally invasive endoscopic ICH evacuation with a new, FDA-approved device called the Apollo System.